Cancer Drug Combination Pricing: Genentech Offers Model For Tecentriq, Avastin

Unique NDCs, Medicare reimbursement codes would allow for lower list prices for the drugs when used in combination for lung cancer, Genentech says.  

vialandmultiplesyringes_1200x675

More from Pricing Debate

More from Market Access